| http://www.w3.org/ns/prov#value | - We look forward to enrolling patients in our OMS824 Phase 2 clinical trial for Huntington's disease within the next few weeks.About Omeros' PDE10 ProgramPDE10 is an enzyme that is expressed in areas of the brain linked to diseases that affect cognition and psychomotor functions, including Huntington's disease and schizophrenia.
|
